Medtronic plc. (MDT) Stock Analysis
Recovery setup
Healthcare · Medical Devices
Hold if already holding. Not a fresh buy at $80.22, but acceptable to hold if already in. Reasons: Thin upside margin: 10.0%; Below 200-MA, MA slope -1.9%/30d (confirmed downtrend).
Medtronic is a global medical device company with four segments—Cardiovascular, Neuroscience, Medical Surgical, and Diabetes—selling device-based therapies and services to healthcare systems in over 150 countries. Revenue is earned from device and consumable sales to hospitals... Read more
Hold if already holding. Not a fresh buy at $80.22, but acceptable to hold if already in. Reasons: Thin upside margin: 10.0%; Below 200-MA, MA slope -1.9%/30d (confirmed downtrend). Chart setup: Death cross but MACD improving, RSI 54. Maintain position. Not compelling to add more. Score 6.0/10, moderate confidence.
Passes 7/9 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 66d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.
Recent developments
updated 2026-06-13Recent Developments — Medtronic plc.
Latest news
- NEWS Can Medtronic (MDT) Close the Growth Gap With Its Bigger MedTech Rivals? - Yahoo Finance — Yahoo Finance neutral
- NEWS Can Medtronic (MDT) Close the Growth Gap With Its Bigger MedTech Rivals? - finance.yahoo.com — finance.yahoo.com positive
- NEWS Medtronic plc stock (IE00BTN1Y115): investors eye upcoming Q4 2026 earnings as options market prices - AD HOC NEWS — AD HOC NEWS neutral
- NEWS Medtronic plc stock (IE00BTN1Y115): Global leader in medical technology - AD HOC NEWS — AD HOC NEWS positive
- NEWS BNY Mellon Dynamic Value Fund's Medtronic PLC(MDT) Holding History - GuruFocus — GuruFocus neutral
Generated 2026-06-15T18:11:46Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $80.22, but acceptable to hold if already in. Reasons: Thin upside margin: 10.0%; Below 200-MA, MA slope -1.9%/30d (confirmed downtrend). Chart setup: Death cross but MACD improving, RSI 54. Maintain position. Not compelling to add more. Target $88.20 (+9.9%), stop $76.16 (−5.3%), A.R:R 1.2:1. Score 6.0/10, moderate confidence.
Take-profit target: $88.20 (+10.0% upside). Target $88.20 (+9.9%), stop $76.16 (−5.3%), A.R:R 1.2:1. Stop-loss: $76.16.
Thin upside margin: 10.0%; Below 200-MA, MA slope -1.9%/30d (confirmed downtrend).
Medtronic plc. trades at a P/E of 21.5 (forward 12.5). TrendMatrix value score: 6.5/10. Verdict: Hold.
37 analysts cover MDT with a consensus score of 3.8/5. Average price target: $98.
What does Medtronic plc. do?Medtronic is a global medical device company with four segments—Cardiovascular, Neuroscience, Medical Surgical, and...
Medtronic is a global medical device company with four segments—Cardiovascular, Neuroscience, Medical Surgical, and Diabetes—selling device-based therapies and services to healthcare systems in over 150 countries. Revenue is earned from device and consumable sales to hospitals and physicians; the company has 95,000+ employees and has announced plans to separate its Diabetes business into an independent public company.